Canine and Feline Parasite Control at Home and Abroad
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Veterinary Guide to Resistance & Parasites
Veterinary Guide to Resistance & Parasites How to make the Get Rotation Right deworming strategy part of your equine health wellness protocol. ||||||||||||||||||||||||||||||||||||||||| GET ROTATION RIGHT Resistant parasites – veterinary involvement is needed now. Deworming has come a long way in the past 50 years – from products that were nearly toxic and required complicated tubing to the easy-to-administer dewormers we know now. As more horse owners recognize the value of regular deworming, past troublemakers such as large strongyles have become much less of a threat. Still, deworming is nothing to take lightly. As internal parasites become more resistant, your expertise is needed Horseowners unknowingly more than ever to make sure deworming programs remain efficient contribute to resistance. and effective. Only with veterinary involvement will we control parasite • Rotating brand names, not populations, combat resistance and get rotation right. chemical classes – general confusion about when and RESISTANCE IS REAL: MULTIPLE DRUGS, MULTIPLE PARASITES. how to use different classes • No new drug class since avermectins in 1981. of dewormers. • Benzimidazole resistance in cyathostomes.1-3 • Lack of knowledge about • Pyrantel resistance in cyathostomes and ascarids.4-8,11 resistance issues. • Ivermectin and moxidectin resistance among ascarids.8,9,11 • Deworming many horses more • Early warning signs of macrocyclic-lactone-resistant cyathostomes.10 frequently than necessary. • Health-related issues caused by parasites: • Misunderstanding about the ~ Ascarids (roundworms) unique properties of larvicidal Verminous pneumonia: cough, nasal discharge, low-grade fever treatments and how to maximize Unthriftiness – rough hair coat their efficacy. Intestinal obstruction/colic • Underdosing their horses. Intestinal perforation leading to peracute death Decreased performance and reduced weight gain ~ Cyathostomes (small strongyles) Most common in young and old horses, but can afflict any horse. -
WSAVA List of Essential Medicines for Cats and Dogs
The World Small Animal Veterinary Association (WSAVA) List of Essential Medicines for Cats and Dogs Version 1; January 20th, 2020 Members of the WSAVA Therapeutic Guidelines Group (TGG) Steagall PV, Pelligand L, Page SW, Bourgeois M, Weese S, Manigot G, Dublin D, Ferreira JP, Guardabassi L © 2020 WSAVA All Rights Reserved Contents Background ................................................................................................................................... 2 Definition ...................................................................................................................................... 2 Using the List of Essential Medicines ............................................................................................ 2 Criteria for selection of essential medicines ................................................................................. 3 Anaesthetic, analgesic, sedative and emergency drugs ............................................................... 4 Antimicrobial drugs ....................................................................................................................... 7 Antibacterial and antiprotozoal drugs ....................................................................................... 7 Systemic administration ........................................................................................................ 7 Topical administration ........................................................................................................... 9 Antifungal drugs ..................................................................................................................... -
These Ain't Your Father's Parasites: Dewormer Resistance and New Strategies for Parasite Control in Horses
These Ain't Your Father's Parasites: Dewormer Resistance and New Strategies for Parasite Control in Horses Ray M. Kaplan, DVM, PhD, DEVPC Department of Infectious Diseases College of Veterinary Medicine University of Georgia Athens, Georgia 30602 Summary Most veterinarians continue to recommend anthelmintic (dewormer) treatment programs for horses that are based on knowledge and concepts that are more than 40 years old. However, recent studies demonstrate that resistance and multiple-drug resistance in equine parasites is extremely common, but few horse owners or veterinarians take this into account when making treatment decisions. Parasites are highly over-dispersed in hosts, such that a small percentage of hosts (20%) harbor most (80%) of the parasites. The common practices of recommending the same treatment program for all horses despite great differences in parasite burdens, of recommending frequent preventive treatment of all horses without any indication of parasitic disease or knowing what species of parasites are present, of recommending the use of drugs without knowledge of their efficacy, of failing to perform fecal egg count surveillance and of failing to determine if treatments are effective, are all incompatible with achieving optimal and sustainable parasite control. Consequently, it is necessary that attitudes and approaches for parasite control in horses undergo a complete overhaul, and that both horse owners and veterinarians become educated in these important issues. Introduction The introduction of benzimidazole (BZ) anthelmintics (dewormers) led to a revolution in equine in parasite control (Drudge and Lyons 1966). With these new tools came new recommendations; horse owners were advised to deworm all horses every 8 weeks. -
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WHO/PSM/QSM/2006.3 The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2006 Programme on International Nonproprietary Names (INN) Quality Assurance and Safety: Medicines Medicines Policy and Standards The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 © World Health Organization 2006 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. -
Taenia Infections Iowa State University Center for Food Security and Public Health
Center for Food Security and Public Health Center for Food Security and Public Health Technical Factsheets 5-1-2005 Taenia Infections Iowa State University Center for Food Security and Public Health Follow this and additional works at: http://lib.dr.iastate.edu/cfsph_factsheets Part of the Animal Diseases Commons, and the Veterinary Infectious Diseases Commons Recommended Citation Iowa State University Center for Food Security and Public Health, "Taenia Infections" (2005). Center for Food Security and Public Health Technical Factsheets. 131. http://lib.dr.iastate.edu/cfsph_factsheets/131 This Report is brought to you for free and open access by the Center for Food Security and Public Health at Iowa State University Digital Repository. It has been accepted for inclusion in Center for Food Security and Public Health Technical Factsheets by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Taenia Etiology Taenia spp. are long, segmented, parasitic tapeworms (family Taeniidae, subclass Infections Cestoda). These parasites have an indirect life cycle, cycling between a definitive and an intermediate host. The following Taenia species are zoonotic, with humans serving Taeniasis, as the definitive host, the intermediate host, or both. Non-zoonotic species of Taenia also exist. Cysticercosis, Neurocysticercosis, Taeniasis Coenurosis, The adult tapeworms live in the intestines of the definitive hosts. This infection is Neurocoenurosis called taeniasis. Humans are the definitive hosts for Taenia solium (the pork tapeworm) and T. saginata (the beef tapeworm). Humans are also the definitive hosts for T. asiatica, a newly recognized tapeworm found in Asia. It is currently uncertain Last Updated: May 2005 whether T. -
Etude Rétrospective Des Déclarations D'effets Indésirables Graves Lors D
Etude rétrospective des déclarations d’effets indésirables graves lors d’utilisation d’antiparasitaires externes chez le chat et le chien Kim Schumacher To cite this version: Kim Schumacher. Etude rétrospective des déclarations d’effets indésirables graves lors d’utilisation d’antiparasitaires externes chez le chat et le chien. Médecine vétérinaire et santé animale. Université Paris-Est Créteil Val de Marne (UPEC); École nationale vétérinaire d’Alfort, 2016. Français. tel- 01874183 HAL Id: tel-01874183 https://tel.archives-ouvertes.fr/tel-01874183 Submitted on 14 Sep 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ÉCOLE NATIONALE VÉTÉRINAIRE D’ALFORT Année 2016 ÉTUDE RÉTROSPECTIVE DES DÉCLARATIONS D’EFFETS INDÉSIRABLES GRAVES LORS D’UTILISATION D’ANTIPARASITAIRES EXTERNES CHEZ LE CHAT ET LE CHIEN THÈSE Pour le DOCTORAT VÉTÉRINAIRE Présentée et soutenue publiquement devant LA FACULTÉ DE MÉDECINE DE CRÉTEIL le…………… par Kim Charlotte Amédée SCHUHMACHER Née le 4 décembre 1991 à Vélizy-Villacoublay (Yvelines) JURY Président : Pr. Professeur à la Faculté de Médecine de CRÉTEIL Membres Directeur : M. PERROT Sébastien Maître de conférences en Pharmacologie à l’ENVA Assesseur : Mme DARMON Céline Maître de conférences en Parasitologie à l’ENVA REMERCIEMENTS Au Professeur de la Faculté de médecine de Créteil, Qui nous a fait l’honneur d’accepter la présidence de notre jury de thèse, Hommage respectueux. -
Sheet1 Page 1 a Abamectin Acetazolamide Sodium Adenosine-5-Monophosphate Aklomide Albendazole Alfaxalone Aloe Vera Alphadolone A
Sheet1 A Abamectin Acetazolamide sodium Adenosine-5-monophosphate Aklomide Albendazole Alfaxalone Aloe vera Alphadolone Acetate Alpha-galactosidase Altrenogest Amikacin and its salts Aminopentamide Aminopyridine Amitraz Amoxicillin Amphomycin Amphotericin B Ampicillin Amprolium Anethole Apramycin Asiaticoside Atipamezole Avoparcin Azaperone B Bambermycin Bemegride Benazepril Benzathine cloxacillin Benzoyl Peroxide Benzydamine Bephenium Bephenium Hydroxynaphthoate Betamethasone Boldenone undecylenate Boswellin Bromelain Bromhexine 2-Bromo-2-nitropan-1, 3 diol Bunamidine Buquinolate Butamisole Butonate Butorphanol Page 1 Sheet1 C Calcium glucoheptonate (calcium glucoheptogluconate) Calcium levulinate Cambendazole Caprylic/Capric Acid Monoesters Carbadox Carbomycin Carfentanil Carnidazole Carnitine Carprofen Cefadroxil Ceftiofur sodium Centella asiatica Cephaloridine Cephapirin Chlorine dioxide Chlormadinone acetate Chlorophene Chlorothiazide Chlorpromazine HCl Choline Salicylate Chondroitin sulfate Clazuril Clenbuterol Clindamycin Clomipramine Clopidol Cloprostenol Clotrimazole Cloxacillin Colistin sulfate Copper calcium edetate Copper glycinate Coumaphos Cromolyn sodium Crystalline Hydroxycobalamin Cyclizine Cyclosporin A Cyprenorphine HCl Cythioate D Decoquinate Demeclocycline (Demethylchlortetracycline) Page 2 Sheet1 Deslorelin Desoxycorticosterone Pivalate Detomidine Diaveridine Dichlorvos Diclazuril Dicloxacillin Didecyl dimethyl ammonium chloride Diethanolamine Diethylcarbamazine Dihydrochlorothiazide Diidohydroxyquin Dimethylglycine -
Simparica Trio
Simparica Trio and Simparica Satisfaction Guarantee If you or your clients feel that Simparica TrioTM (sarolaner, moxidectin, and pyrantel chewable tablets) or Simparica® (sarolaner) Chewables aren’t providing sufficient protection, please call our medical support team to discuss our Satisfaction Guarantee. We will work with you to ensure that you and your clients are satisfied with the performance of Simparica Trio or Simparica or we will refund the cost of your purchase.* The Simparica Trio and Simparica Satisfaction Guarantee is available to any individual who has purchased Simparica Trio or Simparica from a veterinarian or via a veterinarian’s prescription from a Zoetis approved online distributor.** HEARTWORM DISEASE GUIDELINES (SIMPARICA TRIO ONLY): If any dog determined by a licensed veterinarian to be free of heartworm infection at the onset of treatment with Simparica Trio develops heartworm disease, we will provide reimbursement (up to $1,000 and provide Diroban® (melarsomine dihydrochloride) or provide reasonable acquisition costs of melarsomine dihydrochloride) associated with the diagnosis and treatment of heartworm disease and provide a year’s supply of Simparica Trio or ProHeart® 6 (moxidectin) or ProHeart® 12 (moxidectin). Canine Heartworm Reimbursement Requirements: • Simparica Trio was used, at all times, according to its label directions. • Confirmation of heartworm-positive status by two separate blood samples using at least two different brands of antigen tests are required to document heartworm positive status. – The use of an antigen test will be the standard for determining heartworm status. – Knott’s or any filter test for the detection of microfilariae is nots ufficient evidence for pretreatment heartworm negative status. -
NADA FOI Summary
I. GENERAL INFORMATION A. File Number NADA 140-915 B. Sponsor Ciba-Geigy Animal Health Ciba-Geigy Corporation P.O. Box 18300 Greensboro, NC 27419 C. Proprietary Name INTERCEPTOR® D. Established Name milbemycin oxime tablets E. Dosage Form, Route of Administration and Recommended Dosage The ingredients of INTERCEPTOR are formulated into various sized tablets to be administered orally (swallow) as appropriate for the weight of the dog (see below) at monthly dosing intervals. The tablets supply the recommended minimum dose level of 0.5 mg milbemycin oxime per kilogram (0.23 mg/lb.) of body weight. Dog Weight Tablets per Milbemycin Tablet Color Month Oxime per Tablet Up to 10 lbs. 1 2.30 mg Brown 11-25 lbs. 1 5.75 mg Green 26-50 lbs. 1 11.50 mg Yellow 51-100 lbs. 1 23.0 mg White Dogs over 100 lbs. are provided the appropriate combination of these tablets. F. Indication INTERCEPTOR tablets are indicated for use in the prevention of heartworm disease caused by Dirofilaria immitis and control of adult hookworm infections caused by Ancylostoma caninum in dogs. II. EFFECTIVENESS The New Animal Drug Application for milbemycin oxime tablets contains adequate and well-controlled studies which demonstrate efficacy in preventing heartworm disease and controlling hookworm infections in dogs. A. Dose Establishment Thirteen controlled studies were undertaken to establish and confirm the optimal effective dose of milbemycin oxime against the tissue migratory phases of Freedom of Information Summary NADA 140-915 Page 2 of 36 Dirofilaria immitis (canine heartworm) and adult intestinal phases of Ancylostoma sp., principally A. -
EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices
EUROPEAN PHARMACOPOEIA 10.0 Index 1. General notices......................................................................... 3 2.2.66. Detection and measurement of radioactivity........... 119 2.1. Apparatus ............................................................................. 15 2.2.7. Optical rotation................................................................ 26 2.1.1. Droppers ........................................................................... 15 2.2.8. Viscosity ............................................................................ 27 2.1.2. Comparative table of porosity of sintered-glass filters.. 15 2.2.9. Capillary viscometer method ......................................... 27 2.1.3. Ultraviolet ray lamps for analytical purposes............... 15 2.3. Identification...................................................................... 129 2.1.4. Sieves ................................................................................. 16 2.3.1. Identification reactions of ions and functional 2.1.5. Tubes for comparative tests ............................................ 17 groups ...................................................................................... 129 2.1.6. Gas detector tubes............................................................ 17 2.3.2. Identification of fatty oils by thin-layer 2.2. Physical and physico-chemical methods.......................... 21 chromatography...................................................................... 132 2.2.1. Clarity and degree of opalescence of -
Addendum A: Antiparasitic Drugs Used for Animals
Addendum A: Antiparasitic Drugs Used for Animals Each product can only be used according to dosages and descriptions given on the leaflet within each package. Table A.1 Selection of drugs against protozoan diseases of dogs and cats (these compounds are not approved in all countries but are often available by import) Dosage (mg/kg Parasites Active compound body weight) Application Isospora species Toltrazuril D: 10.00 1Â per day for 4–5 d; p.o. Toxoplasma gondii Clindamycin D: 12.5 Every 12 h for 2–4 (acute infection) C: 12.5–25 weeks; o. Every 12 h for 2–4 weeks; o. Neospora Clindamycin D: 12.5 2Â per d for 4–8 sp. (systemic + Sulfadiazine/ weeks; o. infection) Trimethoprim Giardia species Fenbendazol D/C: 50.0 1Â per day for 3–5 days; o. Babesia species Imidocarb D: 3–6 Possibly repeat after 12–24 h; s.c. Leishmania species Allopurinol D: 20.0 1Â per day for months up to years; o. Hepatozoon species Imidocarb (I) D: 5.0 (I) + 5.0 (I) 2Â in intervals of + Doxycycline (D) (D) 2 weeks; s.c. plus (D) 2Â per day on 7 days; o. C cat, D dog, d day, kg kilogram, mg milligram, o. orally, s.c. subcutaneously Table A.2 Selection of drugs against nematodes of dogs and cats (unfortunately not effective against a broad spectrum of parasites) Active compounds Trade names Dosage (mg/kg body weight) Application ® Fenbendazole Panacur D: 50.0 for 3 d o. C: 50.0 for 3 d Flubendazole Flubenol® D: 22.0 for 3 d o. -
Selection of New Chemicals to Be Used in Conditioned Aversion for Non-Lethal Predation Control 2
1 Selection of new chemicals to be used in conditioned aversion for non-lethal predation control 2 3 Jorge Tobajasa,*, Pilar Gómez-Ramíreza,b,c, Pedro María-Mojicab, Isabel Navasb,c, 4 Antonio Juan García-Fernándezb,c, Pablo Ferrerasa, Rafael Mateoa 5 6 aInstituto de Investigación en Recursos Cinegéticos (IREC), CSIC-UCLM-JCCM, Ronda de 7 Toledo No. 12, 13071, Ciudad Real, Spain. 8 bToxicology Area, Department of Health Sciences, Faculty of Veterinary, University of 9 Murcia, Campus de Espinardo, 30100 Murcia, Spain. 10 cToxicology and Risk Assessment Group, Biomedical Research Institute of Murcia (IMIB- 11 Arrixaca), University of Murcia, Campus de Espinardo, 30100 Murcia, Spain. 12 13 *Corresponding author 14 E-mail address: [email protected] (J. Tobajas) 15 1 16 Abstract 17 The use of conditioned food aversion (CFA) can reduce the predation conflict and 18 therefore the incidence of illegal poisoning, which is one of the most important 19 conservation threats for predators and scavengers around the world. CFA is a robust 20 learning paradigm that occurs when animals associate a food with a discomfort 21 induced by a chemical, thereby avoiding that food in subsequent encounters. We 22 reviewed the potential of 167 chemical compounds to be used in CFA, considering 23 effects, margin of safety, accessibility, and detectability. After the review, 15 24 compounds fulfilled the required characteristics, but only five were finally selected to 25 be tested in CFA assays with dogs. Of the tested compounds, thiabendazole, thiram 26 and levamisole caused target food rejection by dogs and reduced the time spent eating 27 during post-conditioning.